Trial Profile
Trans GERD: Efficacy and Tolerability of Esomeprazol in Patients Under Ordinary Medical Care Conditions
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Mar 2008
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary)
- Indications Gastrointestinal disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors AstraZeneca
- 18 Mar 2008 New trial record.